Evotec SE acquired Campus Levi-Montalcini from GlaxoSmithKline plc for 1.
Evotec SE (XTRA:EVT) completed the acquisition of Campus Levi-Montalcini from GlaxoSmithKline plc (LSE:GSK) for 1 on July 1, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,673 GBX | +0.18% | +1.33% | +15.36% |
1st Jan change | Capi. | |
---|---|---|
+15.36% | 85.64B | |
+33.67% | 664B | |
+29.29% | 567B | |
-7.11% | 354B | |
+19.31% | 330B | |
+4.78% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.64% | 148B |